The Vericheck ddPCR Empty-Full Capsid Kits comprise a capsid detection assay in FAM and an ITR-2 assay in HEX. The ITR-2 ...

Production system: Today's launch introduces Asimov’s transient transfection-based AAV manufacturing system—the first in a planned series of releases for AAV Edge.This platform features a ...

PackGene recently built, staffed and equipped a dedicated AAV cGMP facility in Houston, Texas that is scheduled to fully launch in early 2024. AAVs have become the therapeutic gene delivery ...

For central nervous system (CNS) applications, attempts are being made to deliver AAV gene therapy directly to the brain parenchyma or the cerebrospinal fluid (CSF) space by intra-cisterna magna ...

Missed our webinars? Watch the recording of the latest AIrTonomy webinar here. » Facility Unveiling – Witness the introduction of a state-of-the-art testing facility designed to advance AAV technology ...

The US Food and Drug Administration (FDA) has granted clearance to SpliceBio’s investigational new drug (IND) application to ...

From ship to shore to objective, no equipment better defines the distinction and purpose of Marine Corps expeditionary capabilities than the AAV-7 Amphibious Assault Vehicle. Designed to assault ...

Existing gene therapies have primarily used a small number of naturally occurring AAV vectors limited by low delivery efficiency as well as problems with pre-existing immunity and manufacturability.

Astellas has signed another bolt-on deal to build its gene therapy pipeline, agreeing a deal with Dyno Therapeutics to tap into its adeno-associated virus (AAV) vector platform for delivering ...